Status:
RECRUITING
The Osteoarticular Manifestations in Patients With Gitelman Syndrome
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Gitelman Syndrome
CPPD - Calcium Pyrophosphate Deposition Disease
Eligibility:
All Genders
Brief Summary
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.
Detailed Description
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for calcium pyrophosphate deposition, and the clinical data and radiographic manifestations are collected and analyzed...
Eligibility Criteria
Inclusion
- Patients confirmed with Gitelman Syndrome
Exclusion
- Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06922370
Start Date
November 1 2021
End Date
December 1 2025
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the second affiliated hospital, Zhejiang University School of medicine
Hangzhou, Zhejiang, China, 310005